DK3377049T3 - Crystalline forms of tapentadol salts and process for preparation thereof - Google Patents

Crystalline forms of tapentadol salts and process for preparation thereof Download PDF

Info

Publication number
DK3377049T3
DK3377049T3 DK16865892.0T DK16865892T DK3377049T3 DK 3377049 T3 DK3377049 T3 DK 3377049T3 DK 16865892 T DK16865892 T DK 16865892T DK 3377049 T3 DK3377049 T3 DK 3377049T3
Authority
DK
Denmark
Prior art keywords
preparation
crystalline forms
tapentadol salts
tapentadol
salts
Prior art date
Application number
DK16865892.0T
Other languages
English (en)
Inventor
Rajan Srinivasan Thirumalai
Kumar Muppa Kishore
Kumar Anugu Praneeth
Mummadi Venkatesh
Original Assignee
Msn Laboratories Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58718521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3377049(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Msn Laboratories Private Ltd filed Critical Msn Laboratories Private Ltd
Application granted granted Critical
Publication of DK3377049T3 publication Critical patent/DK3377049T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK16865892.0T 2015-11-17 2016-11-16 Crystalline forms of tapentadol salts and process for preparation thereof DK3377049T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN6191CH2015 2015-11-17
PCT/IN2016/000270 WO2017085734A1 (en) 2015-11-17 2016-11-16 Crystalline forms of tapentadol salts and process for preparation thereof

Publications (1)

Publication Number Publication Date
DK3377049T3 true DK3377049T3 (en) 2021-04-12

Family

ID=58718521

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16865892.0T DK3377049T3 (en) 2015-11-17 2016-11-16 Crystalline forms of tapentadol salts and process for preparation thereof

Country Status (7)

Country Link
EP (1) EP3377049B1 (da)
DK (1) DK3377049T3 (da)
ES (1) ES2860907T3 (da)
HR (1) HRP20210503T1 (da)
HU (1) HUE054338T2 (da)
PL (1) PL3377049T3 (da)
WO (1) WO2017085734A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3650439T (pt) 2010-07-23 2021-03-03 Gruenenthal Gmbh Sais ou cocristais de 3-(3-dimetilamino-1-etil-2-metilpropil)fenol
DE202020005470U1 (de) 2020-11-10 2022-01-25 Grünenthal GmbH Darreichungsformen mit verlängerter Freisetzung eines Salzes von Tapentadol mit L-(+)-Weinsäure
PE20240113A1 (es) 2020-11-10 2024-01-22 Gruenenthal Chemie Formas de dosificacion de liberacion sostenida de una sal de tapentadol con acido l-(+)-tartarico
RS63521B1 (sr) 2020-11-10 2022-09-30 Gruenenthal Gmbh Oblici doze sa produženim oslobađanjem soli tapentadola sa l-(+)-vinskom kiselinom
EP4011369A1 (en) 2020-12-14 2022-06-15 G.L. Pharma GmbH Aqueous pharmaceutical composition comprising tapentadol tartrate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
AR053304A1 (es) 2004-07-01 2007-05-02 Gruenenthal Gmbh Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
TWI496762B (zh) 2006-07-24 2015-08-21 歌林達股份有限公司 製備(1r,2r)-3-(3-二甲胺基-1-乙基-2-甲基-丙基)-酚之方法
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
US8288592B2 (en) * 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
PT3650439T (pt) 2010-07-23 2021-03-03 Gruenenthal Gmbh Sais ou cocristais de 3-(3-dimetilamino-1-etil-2-metilpropil)fenol
WO2012051246A1 (en) * 2010-10-12 2012-04-19 Ratiopharm Gmbh Tapentadol hydrobromide and crystalline forms thereof
WO2014108514A1 (en) * 2013-01-10 2014-07-17 Farma Grs, D. O. O. Tapentadol maleate and crystalline forms thereof
CN103553940A (zh) * 2013-11-07 2014-02-05 南京艾德凯腾生物医药有限责任公司 一种新晶型盐酸他喷他多的制备方法

Also Published As

Publication number Publication date
EP3377049A4 (en) 2019-06-12
PL3377049T3 (pl) 2021-06-28
EP3377049A1 (en) 2018-09-26
WO2017085734A1 (en) 2017-05-26
ES2860907T3 (es) 2021-10-05
EP3377049B1 (en) 2021-01-06
HRP20210503T1 (hr) 2021-10-15
HUE054338T2 (hu) 2021-08-30

Similar Documents

Publication Publication Date Title
IL255738A (en) A new crystalline form of lenbatinib mesylate and a process for its preparation
HUP1400475A2 (en) Novel process for preparation of treprostinil and its salts
PT3580219T (pt) Processo para a preparação de remimazolam e formas de estado sólido de sais de remimazolam
PL3174988T3 (pl) Sposób wytwarzania kwasu mlekowego
SMT202500228T1 (it) Forme cristalline di ozanimod e ozanimod cloridrato, e processi per la loro preparazione
IL248656A0 (en) A system for preparing seeds and a method for use
IL254530A0 (en) Preparation method of crystalline form a of pci-32765
SI3380554T1 (sl) Kristalne oblike per-kloro-gama-ciklodekstrinov
SG10202101979TA (en) Crystalline forms of c21h22ci2n4o2
IL272108A (en) New crystal structures of vilanterol tripentate and processes for their preparation
PT3445742T (pt) Fosfato de tapentadol cristalino
HUE054338T2 (hu) Tapentadol sók kristályos formái és eljárás azok elõállítására
HRP20190403T1 (hr) Postupak izrade lakozamida
EP3141540A4 (en) Crystalline form of chlorogenic acid and preparation method therefor
PL3327012T3 (pl) Krystaliczne postacie bilastyny i sposoby ich wytwarzania
EP2945927A4 (en) Process for preparation of fingolimod and its salts
IL253479A0 (en) Crystalline forms of efinconazole
IL254597A0 (en) Crystalline form of ahu377, method for its preparation and use
ZA201607265B (en) A process for preparation of levothyroxine and salts thereof
IL246835A0 (en) Improved process for the preparation of trazodone and its hydrochloride salt
PL3253772T3 (pl) Sposób otrzymywania diosminy
GB2565419B (en) Process for preparing novel crystalline form of mesosulfuron-methyl and use thereof
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
HUP1500647A2 (en) Intermediate of baricitinib and process for its preparation
PT3148961T (pt) Método para preparar um sal do ácido acetilsalicílico e um aminoácido básico